213 related articles for article (PubMed ID: 23541441)
41. [Bone marrow failure due to telomere associated gene mutation].
Yamaguchi H; Dan K
Rinsho Ketsueki; 2010 Aug; 51(8):646-53. PubMed ID: 20805671
[No Abstract] [Full Text] [Related]
42. Telomeres in dyskeratosis congenita.
Shay JW; Wright WE
Nat Genet; 2004 May; 36(5):437-8. PubMed ID: 15118675
[No Abstract] [Full Text] [Related]
43. The shelterin complex and hematopoiesis.
Jones M; Bisht K; Savage SA; Nandakumar J; Keegan CE; Maillard I
J Clin Invest; 2016 May; 126(5):1621-9. PubMed ID: 27135879
[TBL] [Abstract][Full Text] [Related]
44. Dyskeratosis Congenita Links Telomere Attrition to
Age-Related Systemic Energetics.
James EN; Sagi-Kiss V; Bennett M; Mycielska ME; Karen-Ng LP; Roberts T; Matta S; Dokal I; Bundy JG; Parkinson EK
J Gerontol A Biol Sci Med Sci; 2023 May; 78(5):780-789. PubMed ID: 36651908
[TBL] [Abstract][Full Text] [Related]
45. Telomeres, telomerase, and human disease.
Artandi SE
N Engl J Med; 2006 Sep; 355(12):1195-7. PubMed ID: 16990382
[No Abstract] [Full Text] [Related]
46. Multiple pathways to cellular senescence: role of telomerase repressors.
Oshimura M; Barrett JC
Eur J Cancer; 1997 Apr; 33(5):710-5. PubMed ID: 9282109
[TBL] [Abstract][Full Text] [Related]
47. Telomere length, stem cells and aging.
Blasco MA
Nat Chem Biol; 2007 Oct; 3(10):640-9. PubMed ID: 17876321
[TBL] [Abstract][Full Text] [Related]
48. Reprogramming suppresses premature senescence phenotypes of Werner syndrome cells and maintains chromosomal stability over long-term culture.
Shimamoto A; Kagawa H; Zensho K; Sera Y; Kazuki Y; Osaki M; Oshimura M; Ishigaki Y; Hamasaki K; Kodama Y; Yuasa S; Fukuda K; Hirashima K; Seimiya H; Koyama H; Shimizu T; Takemoto M; Yokote K; Goto M; Tahara H
PLoS One; 2014; 9(11):e112900. PubMed ID: 25390333
[TBL] [Abstract][Full Text] [Related]
49. The wide-ranging clinical implications of the short telomere syndromes.
Barbaro PM; Ziegler DS; Reddel RR
Intern Med J; 2016 Apr; 46(4):393-403. PubMed ID: 26247919
[TBL] [Abstract][Full Text] [Related]
50. Understanding telomere diseases through analysis of patient-derived iPS cells.
Batista LF; Artandi SE
Curr Opin Genet Dev; 2013 Oct; 23(5):526-33. PubMed ID: 23993228
[TBL] [Abstract][Full Text] [Related]
51. Telomere biology disorders may manifest as common variable immunodeficiency (CVID).
Rolles B; Caballero-Oteyza A; Proietti M; Goldacker S; Warnatz K; Camacho-Ordonez N; Prader S; Schmid JP; Vieri M; Isfort S; Meyer R; Kirschner M; Brümmendorf TH; Beier F; Grimbacher B
Clin Immunol; 2023 Dec; 257():109837. PubMed ID: 37944684
[TBL] [Abstract][Full Text] [Related]
52. Impaired reproductive function and fertility preservation in a woman with a dyskeratosis congenita.
Robinson LG; Pimentel R; Wang F; Kramer YG; Gonullu DC; Agarwal S; Navarro PA; McCulloh D; Keefe DL
J Assist Reprod Genet; 2020 May; 37(5):1221-1225. PubMed ID: 32405899
[TBL] [Abstract][Full Text] [Related]
53. Telomeres and diseases.
Agarwal MB
J Assoc Physicians India; 2014 Oct; 62(10):9-11. PubMed ID: 25906514
[No Abstract] [Full Text] [Related]
54. Unraveling the pathogenesis of Hoyeraal-Hreidarsson syndrome, a complex telomere biology disorder.
Glousker G; Touzot F; Revy P; Tzfati Y; Savage SA
Br J Haematol; 2015 Aug; 170(4):457-71. PubMed ID: 25940403
[TBL] [Abstract][Full Text] [Related]
55. A unique homozygous WRAP53 Arg298Trp mutation underlies dyskeratosis congenita in a Chinese Han family.
Shao Y; Feng S; Huang J; Huo J; You Y; Zheng Y
BMC Med Genet; 2018 Mar; 19(1):40. PubMed ID: 29514627
[TBL] [Abstract][Full Text] [Related]
56. Dyskeratosis congenita. A disease of premature ageing.
Dokal I
Lancet; 2001 Dec; 358 Suppl():S27. PubMed ID: 11784576
[No Abstract] [Full Text] [Related]
57. A mouse model of Werner Syndrome: what can it tell us about aging and cancer?
Chang S
Int J Biochem Cell Biol; 2005 May; 37(5):991-9. PubMed ID: 15743673
[TBL] [Abstract][Full Text] [Related]
58. A regulatory loop connecting WNT signaling and telomere capping: possible therapeutic implications for dyskeratosis congenita.
Fernandez RJ; Johnson FB
Ann N Y Acad Sci; 2018 Apr; 1418(1):56-68. PubMed ID: 29722029
[TBL] [Abstract][Full Text] [Related]
59. An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.
Niewisch MR; Savage SA
Expert Rev Hematol; 2019 Dec; 12(12):1037-1052. PubMed ID: 31478401
[No Abstract] [Full Text] [Related]
60. Pulmonary arteriovenous malformations: an uncharacterised phenotype of dyskeratosis congenita and related telomere biology disorders.
Khincha PP; Bertuch AA; Agarwal S; Townsley DM; Young NS; Keel S; Shimamura A; Boulad F; Simoneau T; Justino H; Kuo C; Artandi S; McCaslin C; Cox DW; Chaffee S; Collins BF; Giri N; Alter BP; Raghu G; Savage SA
Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 27824607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
